Champions Oncology, Inc.
CSBR
$8.85
$0.242.79%
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 17.04M | 13.49M | 14.06M | 14.00M | 12.02M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 17.04M | 13.49M | 14.06M | 14.00M | 12.02M |
| Cost of Revenue | 6.62M | 7.43M | 7.07M | 7.25M | 7.85M |
| Gross Profit | 10.42M | 6.06M | 6.99M | 6.75M | 4.17M |
| SG&A Expenses | 4.20M | 3.64M | 4.21M | 4.54M | 4.56M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.54M | 12.76M | 12.73M | 13.84M | 14.60M |
| Operating Income | 4.50M | 732.00K | 1.33M | 164.00K | -2.58M |
| Income Before Tax | 4.52M | 739.00K | 1.33M | -190.00K | -2.52M |
| Income Tax Expenses | 23.00K | 11.00K | 21.00K | -81.00K | 11.00K |
| Earnings from Continuing Operations | 4.50M | 728.00K | 1.31M | -109.00K | -2.53M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 4.50M | 728.00K | 1.31M | -109.00K | -2.53M |
| EBIT | 4.50M | 732.00K | 1.33M | 164.00K | -2.58M |
| EBITDA | 4.90M | 1.13M | 1.78M | 621.00K | -2.10M |
| EPS Basic | 0.33 | 0.05 | 0.10 | -0.01 | -0.19 |
| Normalized Basic EPS | 0.21 | 0.03 | 0.06 | 0.01 | -0.12 |
| EPS Diluted | 0.31 | 0.05 | 0.09 | -0.01 | -0.19 |
| Normalized Diluted EPS | 0.20 | 0.03 | 0.06 | 0.01 | -0.12 |
| Average Basic Shares Outstanding | 13.70M | 13.59M | 13.59M | 13.59M | 13.59M |
| Average Diluted Shares Outstanding | 14.36M | 14.02M | 14.04M | 13.59M | 13.59M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
